PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH
🇵🇬Papua New Guinea
- Country
- 🇵🇬Papua New Guinea
- Ownership
- -
- Established
- 1968-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.pngimr.org.pg/
Clinical Trials
9
Active:0
Completed:6
Trial Phases
4 Phases
Phase 2:1
Phase 3:1
Phase 4:4
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Phase 4
4 (44.4%)Not Applicable
3 (33.3%)Phase 2
1 (11.1%)Phase 3
1 (11.1%)A Safety, Tolerability, Pharmacokinetic and Efficacy Study of Azithromycin Plus Piperaquine as Presumptive Treatment in Pregnant PNG Women
Phase 4
- Conditions
- PregnancyInfections, PlasmodiaDrug KineticsClinical Efficacy
- Interventions
- First Posted Date
- 2015-10-15
- Last Posted Date
- 2015-10-15
- Lead Sponsor
- Papua New Guinea Institute of Medical Research
- Target Recruit Count
- 150
- Registration Number
- NCT02575755
- Locations
- 🇵🇬
Papua New Guinea Institute of Medical Research, Madang, Madang Province, Papua New Guinea
Investigation of Short Course, High Dose Primaquine Treatment for Liver Stages of Plasmodium Vivax Infection
- First Posted Date
- 2015-02-18
- Last Posted Date
- 2015-10-14
- Lead Sponsor
- Papua New Guinea Institute of Medical Research
- Target Recruit Count
- 150
- Registration Number
- NCT02364583
- Locations
- 🇵🇬
PNG Institute of Medical Research, Madang, Madang Province, Papua New Guinea
Effect of Liver and Blood-stage Treatment on Subsequent Plasmodium Reinfection and Morbidity
Phase 4
Completed
- Conditions
- Plasmodium Vivax InfectionPlasmodium Vivax Clinical EpisodePlasmodium Falciparum InfectionPlasmodium Falciparum Clinical Episode
- Interventions
- First Posted Date
- 2014-05-21
- Last Posted Date
- 2014-05-21
- Lead Sponsor
- Papua New Guinea Institute of Medical Research
- Target Recruit Count
- 524
- Registration Number
- NCT02143934
- Locations
- 🇵🇬
PNG Institute of Medical Research, Maprik, East Sepik Province, Papua New Guinea
Safety and Immunogenicity of 10-valent and 13-valent Pneumococcal Conjugate Vaccines in Papua New Guinean Children
Phase 3
- Conditions
- MeningitisOtitis MediaSepsisPneumoniaBacteraemia
- First Posted Date
- 2012-06-14
- Last Posted Date
- 2014-03-21
- Lead Sponsor
- Papua New Guinea Institute of Medical Research
- Target Recruit Count
- 200
- Registration Number
- NCT01619462
- Locations
- 🇵🇬
Papua New Guinea Institute of Medical Research, Goroka, Eastern Highlands Province, Papua New Guinea
Artemether-Lumefantrine Clinical Effectiveness Study
Phase 4
Completed
- Conditions
- Parasitologically Confirmed; Malarial
- Interventions
- Drug: Artemether-lumefantrine combination
- First Posted Date
- 2012-05-15
- Last Posted Date
- 2012-08-16
- Lead Sponsor
- Papua New Guinea Institute of Medical Research
- Target Recruit Count
- 159
- Registration Number
- NCT01599000
- Locations
- 🇵🇬
Gurney Health Centre, Alotau, Milne Bay, Papua New Guinea
- Prev
- 1
- 2
- Next
News
No news found